+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Peanut Allergy Drug"

From
Peanut Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Peanut Allergy (PA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Peanut Allergy (PA) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 76 Pages
  • Global
From
From
Peanut Allergy: Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

Peanut Allergy: Opportunity Analysis and Forecasts to 2027

  • Report
  • June 2018
  • 124 Pages
  • Global
From
Peanut Allergy - Pipeline Review, H2 2020 - Product Thumbnail Image

Peanut Allergy - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 170 Pages
  • Global
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Peanut Allergy Drug market is a subset of the Allergy Drugs market, which is composed of pharmaceuticals used to treat allergic reactions. Peanut Allergy Drugs are specifically designed to treat allergic reactions to peanuts, which can range from mild to life-threatening. These drugs are typically administered in the form of an injection, and are designed to reduce the severity of allergic reactions. The Peanut Allergy Drug market is highly competitive, with a number of companies offering products to treat peanut allergies. These companies include Aimmune Therapeutics, DBV Technologies, and Allergen Research Corporation. Other companies in the market include AnaptysBio, Inc., and Allergy Therapeutics plc. Show Less Read more